Thomas Mackie

Cellectar, Inc. is a clinical stage radiopharmaceutical company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar began independent lab activities in February 2003 after forming a company and raising initial funds in the 2000-2002 timeframe. Its product candidates combine phospholipids ethers analogs (PLEs), which are lipid-like molecules, with radioisotopes that destroy or image malignant cancer cells. Because only malignant tumor cells and tissues retain large amounts of these compounds, malignant cancer-selective retention of therapeutic or diagnostic doses of radioactivity can be achieved. Cellectar has demonstrated specific uptake and retention of its product candidates in more than 45 tumor types tested in proof-of-principle preclinical animal studies. In addition, ten preclinical experiments have shown anti-tumor activity in each tumor type studied including breast, prostate, lung, glioma, pancreatic, melanoma, ovarian, uterine, renal and colorectal cancers. The compound, originally known as NM404, is being taken through the regulatory process as CLR1404. Capitalizing on the unique characteristics of malignant cancer cells, Cellectar's molecules will be designed to find, treat and follow malignancies through the delivery of radiopharmaceuticals in a novel, highly selective way.

Wisconsin Investment Partners LLC (Wisconsin Investment Partners) is a venture capital firm founded in 2000 by Dick Leazer and Terry Sivesind. The firm is headquartered in Madison, Wisconsin.

Asto CT, Inc. engages in the development of x-ray computed tomography for imaging to prevent equine fractures for horses. It offers Equina, a multi-slice helical CT that allows simultaneous imaging of two limbs of a standing, sedated equine patient. The company was founded by Thomas Rockwell Mackie, Peter Muir, David L. Ergun, and Mark D. Markel in 2015 and is headquartered in Madison, WI.

OnLume, Inc. operates as a medical device company. It provides ergonomic solutions for precise fluorescence image-guided surgery. The company was founded by Adam Uselmann, Benjamin Titz, Andreas Velten, Kevin Eliceiri and Thomas Rockwell Mackie and is headquartered in Madison, WI.

Part of Asto CT, Inc., DC Leo Cancer Care Ltd. is a British company that aims to improve the quality of Radiation Therapy delivery and access to Radiation Therapy through the removal of gantries. The company is based in Smallfield, UK. The company's approach is built on research from across the globe showing the benefits of upright patient positioning, combined with a shift from machine rotation to patient rotation. Leo Cancer Care offers upright Proton Therapy, Radiology, and Photon Therapy solutions that provide key features and benefits to patients. The company's mission is to find a better way, a more human way to treat cancer. Leo Cancer Care was founded in 2018 by Thomas Rockwell Mackie. The CEO is Stephen Kevin Towe.

Part of Asto CT, Inc., Leo Cancer Care Ltd is a British company that provides upright proton therapy, radiology, and photon therapy solutions for cancer treatment. The company is based in Smallfield, UK. The company's approach is built on research from across the globe, showing the benefits of upright patient positioning and a shift from machine rotation to patient rotation, which is set to change the face of radiation therapy for good. Leo Cancer Care was founded in 2018 by Stephen Kevin Towe and Thomas Rockwell Mackie, with Stephen Kevin Towe serving as the CEO since then.

Wisconsin Investment Partners LLC (Wisconsin Investment Partners) is a venture capital firm founded in 2000 by Dick Leazer and Terry Sivesind. The firm is headquartered in Madison, Wisconsin.

SHINE Technologies LLC manufactures radioisotopes for nuclear medicine. Its products include Molybdenum-99, Iodine-131, Iodine-125, and Xenon-133. The company was founded by Gregory R. Piefer and is headquartered in Monona, WI.

Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI.

TomoTherapy, Inc. manufactures and provides radiation treatment systems for advanced radiation therapy. It provides radiation treatment services for cancer patients with its TomoTherapy Hi·Art System, which changes the intensity of the radiation beam so that it adapts to the shape of the tumor. The firm's system focuses on killing cancer cells while sparing healthy tissue. The company was founded by Thomas Rockwell Mackie and Paul J. Reckwerdt in 1997 and is headquartered in Madison, WI.

TomoTherapy, Inc. manufactures and provides radiation treatment systems for advanced radiation therapy. It provides radiation treatment services for cancer patients with its TomoTherapy Hi·Art System, which changes the intensity of the radiation beam so that it adapts to the shape of the tumor. The firm's system focuses on killing cancer cells while sparing healthy tissue. The company was founded by Thomas Rockwell Mackie and Paul J. Reckwerdt in 1997 and is headquartered in Madison, WI.

Asto CT, Inc. engages in the development of x-ray computed tomography for imaging to prevent equine fractures for horses. It offers Equina, a multi-slice helical CT that allows simultaneous imaging of two limbs of a standing, sedated equine patient. The company was founded by Thomas Rockwell Mackie, Peter Muir, David L. Ergun, and Mark D. Markel in 2015 and is headquartered in Madison, WI.

SHINE Technologies LLC manufactures radioisotopes for nuclear medicine. Its products include Molybdenum-99, Iodine-131, Iodine-125, and Xenon-133. The company was founded by Gregory R. Piefer and is headquartered in Monona, WI.

Illuminated Holdings, Inc. operates as an investment holding company. The company is headquartered in Janesville, WI.

OnLume, Inc. operates as a medical device company. It provides ergonomic solutions for precise fluorescence image-guided surgery. The company was founded by Adam Uselmann, Benjamin Titz, Andreas Velten, Kevin Eliceiri and Thomas Rockwell Mackie and is headquartered in Madison, WI.

Illuminated Holdings, Inc. operates as an investment holding company. The company is headquartered in Janesville, WI.

SHINE Technologies LLC manufactures radioisotopes for nuclear medicine. Its products include Molybdenum-99, Iodine-131, Iodine-125, and Xenon-133. The company was founded by Gregory R. Piefer and is headquartered in Monona, WI.

Wisconsin Investment Partners LLC (Wisconsin Investment Partners) is a venture capital firm founded in 2000 by Dick Leazer and Terry Sivesind. The firm is headquartered in Madison, Wisconsin.

The Morgridge Institute for Research, Inc. is a biosciences research institution. The private company is based in Madison, WI. The CEO of the company is Brad Schwartz.

OnLume, Inc. operates as a medical device company. It provides ergonomic solutions for precise fluorescence image-guided surgery. The company was founded by Adam Uselmann, Benjamin Titz, Andreas Velten, Kevin Eliceiri and Thomas Rockwell Mackie and is headquartered in Madison, WI.

OnLume, Inc. operates as a medical device company. It provides ergonomic solutions for precise fluorescence image-guided surgery. The company was founded by Adam Uselmann, Benjamin Titz, Andreas Velten, Kevin Eliceiri and Thomas Rockwell Mackie and is headquartered in Madison, WI.

Illuminated Holdings, Inc. operates as an investment holding company. The company is headquartered in Janesville, WI.

SHINE Technologies LLC manufactures radioisotopes for nuclear medicine. Its products include Molybdenum-99, Iodine-131, Iodine-125, and Xenon-133. The company was founded by Gregory R. Piefer and is headquartered in Monona, WI.

Illuminated Holdings, Inc. operates as an investment holding company. The company is headquartered in Janesville, WI.

SHINE Technologies LLC manufactures radioisotopes for nuclear medicine. Its products include Molybdenum-99, Iodine-131, Iodine-125, and Xenon-133. The company was founded by Gregory R. Piefer and is headquartered in Monona, WI.

The Morgridge Institute for Research, Inc. is a biosciences research institution. The private company is based in Madison, WI. The CEO of the company is Brad Schwartz.